Funder: American Association for Cancer Research
Due Dates: June 4, 2026 (Full application, 1:00 p.m. U.S. Eastern Time)
Funding Amounts: $350,000 total over 3 years (direct and indirect costs included)
Summary: Supports independent investigators advancing research on Tumor Treating Fields (TTFields) in cancer, requiring use of Novocure’s Inovitro®/inovivo® systems.
Key Information: Applicants must be AACR Active members in good standing by the deadline; research must incorporate Inovitro®/inovivo® systems.